Baxter International Inc. Issues New Senior Unsecured Notes
Ticker: BAX · Form: 8-K · Filed: Jul 18, 2024 · CIK: 10456
Sentiment: neutral
Topics: debt-issuance, financing, notes
Related Tickers: BAX
TL;DR
Baxter just took on new debt with notes due 2024, 2025, and 2029.
AI Summary
On July 17, 2024, Baxter International Inc. entered into a material definitive agreement related to the issuance of senior unsecured notes. This agreement involves the creation of a direct financial obligation for the company, specifically concerning notes due in 2024, 2025, and 2029.
Why It Matters
This filing indicates Baxter International Inc. is undertaking new debt financing, which could impact its capital structure and future financial obligations.
Risk Assessment
Risk Level: medium — Issuing new debt can increase financial leverage and obligations, potentially impacting the company's financial health and credit rating.
Key Players & Entities
- BAXTER INTERNATIONAL INC (company) — Filer
- 2024-07-17 (date) — Date of Report
- 2024 (date) — Maturity Year of Notes
- 2025 (date) — Maturity Year of Notes
- 2029 (date) — Maturity Year of Notes
FAQ
What type of agreement did Baxter International Inc. enter into on July 17, 2024?
Baxter International Inc. entered into a material definitive agreement related to the creation of a direct financial obligation, specifically the issuance of senior unsecured notes.
What are the maturity dates for the notes mentioned in the filing?
The filing mentions notes with maturity dates in 2024, 2025, and 2029.
What is the filing type and date?
The filing is a Form 8-K, filed on July 18, 2024, reporting events as of July 17, 2024.
What is Baxter International Inc.'s Standard Industrial Classification code?
Baxter International Inc.'s Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
What is the company's principal business address?
The company's principal business address is One Baxter Parkway, Deerfield, IL 60015.
Filing Stats: 968 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2024-07-18 16:46:05
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value BAX (NYSE) New York Stock
- $2.05 billion — an aggregate principal amount of up to $2.05 billion (the " Advances "). The Advances will
Filing Documents
- d867131d8k.htm (8-K) — 36KB
- d867131dex101.htm (EX-10.1) — 502KB
- 0001193125-24-181060.txt ( ) — 843KB
- bax24-20240717.xsd (EX-101.SCH) — 4KB
- bax24-20240717_def.xml (EX-101.DEF) — 16KB
- bax24-20240717_lab.xml (EX-101.LAB) — 25KB
- bax24-20240717_pre.xml (EX-101.PRE) — 16KB
- d867131d8k_htm.xml (XML) — 10KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits. Exhibit Number Description 10.1 Credit Agreement, dated as of July 17, 2024, among Baxter International Inc. as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent, and certain other financial institutions named therein. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BAXTER INTERNATIONAL INC. Date: July 18, 2024 By: /s/ Ellen K. Bradford Name: Ellen K. Bradford Title: Senior Vice President and Corporate Secretary